Navigation Links
Neuro-Biotech Corp. Neuroceuticals® : A solution to feed the brain
Date:11/10/2010

Neuro-Biotech Corp. Neuroceuticals® : A solution to feed the brain


Advanced Search Search

  
Close
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Biotechnology, New Products & Services Click to view news release full screen  

Neuro-Biotech Corp. Neuroceuticals® : A solution to feed the brain

 

BASEL, Switzerland, Nov. 10 /PRNewswire/ - Neuro-Biotech Corporation (PINKSHEET: MRES) (OTCQB: MRES)

Neuro-Biotech Corp. is currently actively working towards the commercialization of natural products called "Neuroceuticals®", that are specially designed to restore the nervous system equilibrium and improve the state of health as well as the quality of life of people affected by stress-related disorders.

Our "Neuroceuticals®" respect international established quality standards (USP, EP and JP) in regards with purity, strength, and consistency of the products for human consumption.

According with our licences, we have a portfolio of four (4) innovative and selective products.

  • Neuro-Relax®
    A protein based supplement that favours the sleep's quality, decreases the anxiety and nervous pressure, improves general anxiety, anxious disorders, physical, emotional and mental stress and has a tranquilizing and soothing effect
  • Neuro-Learn®
    An adaptogene that helps stimulating the noradregenic and cholinergic systems resulting in improvement with memory, depression, concentration, attention and vigilance in particular with children suffering from attention deficit disorder which often need treatment with methylphenidate, among others marketed under the name of Ritalin®.
  • Neuro-Stim®
    An adoptogene which effect results in an increase in energy in order to reduce the effects of depression, hypoglycaemia, stress, obesity and type II diabetes as well as food behaviour's disorders such as bulimia.
  • Neuro-Lean®
    A product specially conceived to help with weight-loss management, optimizing the energetic spending as well as maintaining body weight.
  • Those four (4) products will be sold and distributed by many means; directly from us under our own label as well as through "Private labels" such as pharmacies, megastore and natural products brands. Since we are actively in a negotiation process, it will be the distributor's mandate, in terms of their respective part of the market, to target the clientele they believe should be reached.

    For more detailed information on the scientific data and the Neuroceuticals®, we invite you to consult our website at neuro-biotechcorp.com under the products section.

    Neuro-Biotech is currently negotiating with 2 separates groups on the East coast and West coast for them to distribute the Neuroceuticals®. Management also decided that in order to maximize the market penetration and based on the product composition, it was it the Company's best interest to categorize the Neuroceuticals® as Natural Products and Food Supplements.

    For more information, do not hesitate to contact us by using the contact form on our corporate website at neuro-biotechcorp.com. Your request will be transferred to the appropriate persons and we will get back to you as soon as possible.


    '/>"/>
    SOURCE Neuro-Biotech Corp.
    Copyright©2010 PR Newswire.
    All rights reserved

    Related biology technology :

    1. Mr Claude Poulin nominated as President and CEO of Neuro-Biotech Corp.
    2. Neuro-Biotechs Solution for a Doctor near You: Early Detection for Alzheimers and Chronic Fatigue Syndrome!
    3. NEURO-BIOTECH DISCLOSES ITS LIST OF LICENSES
    4. NEURO-BIOTECH CORPORATION: Updates and latest developments
    5. BioSpecifics Technologies Corp. Reports Second Quarter 2008 Financial Results
    6. InstaCare Corp. Continues Turnaround & Reports 291% Revenues Increase in 2Q 2008
    7. ThermoGenesis Corp. to Announce Fourth Quarter and Year End Results for Fiscal 2008 on September 9, 2008
    8. BioSpecifics Technologies Corp. Buys Down Royalties for Peyronies Disease
    9. Aegis Analytical Corp. Showcases Discoverant at Inaugural Venture Capital in the Rockies Fall
    10. BioElectronics Corp. Announces $400,000 in New Orders From the Middle East
    11. BioSpecifics Technologies Corp. Announces Appointment of Dr. Matthew Geller to Board of Directors
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:2/24/2017)... (PRWEB) , ... February 24, 2017 , ... ... (TDR) procedures can be safely completed in an ambulatory surgery center (ASC) with ... (ACDF) procedures and previous two-year TDR studies. , Jake Lubinski, president of ...
    (Date:2/24/2017)... ... February 24, 2017 , ... Chef Jodi Abel has returned from her ... several cities, she gained a number of delicious recipes and new techniques to share ... South Africa’s Western Cape province. It is internationally renowned for its incredible wine ...
    (Date:2/24/2017)... 2017  Aethlon Medical, Inc. (Nasdaq: AEMD ... Chairman and CEO, Jim Joyce . ... last Saturday, Bill Gates warned world leaders ... than nuclear weapons. Mr. Gates expressed his concern, which ... that scientific terrorists have access to the necessary tools ...
    (Date:2/24/2017)... 2017  Driven by consumers, preference towards more ... fastest growing categories, finds the recently published U.S. ... Care: Multi-regional Market Analysis and Opportunities study ... Kline. "Biotechnology actives are derived from ... effective for skin and hair care applications," explains ...
    Breaking Biology Technology:
    (Date:2/26/2017)... , Feb. 25, 2017  Securus Technologies, a ... solutions for public safety, investigation, corrections and monitoring, ... and Reentry. "Too often, too many ... and county jails are trying to tackle this ... and friends and family members. While significant steps are ...
    (Date:2/21/2017)... LONDON , February 21, 2017 ... um 70 Millionen US-Dollar wachsen. Nach einem Gespräch mit mehr ... es einige Hindernisse zu überwinden gilt, um diese Prognose ... ... unter anderem die Mobilisierung der finanziellen Mittel für die ...
    (Date:2/13/2017)... , Feb. 13, 2017 Former 9/11 Commission ... Judiciary Committee, Janice Kephart of Identity Strategy ... Donald Trump,s "Executive Order: Protecting the Nation ... 27, 2017):  "As President Trump,s ,Travel Ban, ... has now essentially banned the travel ban, it is ...
    Breaking Biology News(10 mins):